EVENITY Subcutaneous Injection 105mg Syringe, manufactured by Amgen, contains Romosozumab (genetical recombination) (YJ code: 3999449G1025, 105mg 1.17mL tube). This sclerostin inhibitor is used for osteoporosis in postmenopausal women at high risk of fracture, increasing bone formation and decreasing bone resorption.
EVENITY Subcutaneous Injection 105mg Syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
